1. Home
  2. RDW vs HCM Comparison

RDW vs HCM Comparison

Compare RDW & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDW
  • HCM
  • Stock Information
  • Founded
  • RDW 2020
  • HCM 2000
  • Country
  • RDW United States
  • HCM Hong Kong
  • Employees
  • RDW N/A
  • HCM N/A
  • Industry
  • RDW Military/Government/Technical
  • HCM Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDW Industrials
  • HCM Health Care
  • Exchange
  • RDW Nasdaq
  • HCM Nasdaq
  • Market Cap
  • RDW 2.2B
  • HCM 2.5B
  • IPO Year
  • RDW N/A
  • HCM N/A
  • Fundamental
  • Price
  • RDW $14.33
  • HCM $18.45
  • Analyst Decision
  • RDW Strong Buy
  • HCM Buy
  • Analyst Count
  • RDW 8
  • HCM 2
  • Target Price
  • RDW $17.91
  • HCM $23.50
  • AVG Volume (30 Days)
  • RDW 4.0M
  • HCM 58.9K
  • Earning Date
  • RDW 08-06-2025
  • HCM 08-07-2025
  • Dividend Yield
  • RDW N/A
  • HCM N/A
  • EPS Growth
  • RDW N/A
  • HCM N/A
  • EPS
  • RDW N/A
  • HCM 0.04
  • Revenue
  • RDW $277,704,000.00
  • HCM $630,201,000.00
  • Revenue This Year
  • RDW $46.40
  • HCM $15.00
  • Revenue Next Year
  • RDW $44.30
  • HCM $19.91
  • P/E Ratio
  • RDW N/A
  • HCM $86.49
  • Revenue Growth
  • RDW 1.36
  • HCM N/A
  • 52 Week Low
  • RDW $4.87
  • HCM $11.51
  • 52 Week High
  • RDW $26.66
  • HCM $21.50
  • Technical
  • Relative Strength Index (RSI)
  • RDW 40.91
  • HCM 76.45
  • Support Level
  • RDW $15.88
  • HCM $17.36
  • Resistance Level
  • RDW $16.51
  • HCM $18.00
  • Average True Range (ATR)
  • RDW 1.36
  • HCM 0.36
  • MACD
  • RDW -0.33
  • HCM 0.16
  • Stochastic Oscillator
  • RDW 6.84
  • HCM 91.83

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

Share on Social Networks: